Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease

HIGHLIGHTS

• who: Niki Katsiki from the This is a non-interventional, observational, phase, trial in PAD patients presenting with ICThe study aimed to assess the safety and efficacy of cilostazol in improving pain symptoms and walking distance at , and , months from cilostazol therapy initiation. Lifestyle measures and drug treatment were also recorded during the follow-up. Inclusion criteria were: age u2265 , years, Fontaine Stage II PAD (IC), current cilostazol treatment and anklebrachial index (ABI), .41-0., (if available). Exclusion criteria were: known hypersensitivity to cilostazol have published the Article: Real world data from a multi-centre study on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.